Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP synthase subunit c of Mycobacterium tuberculosis (AtpE) is an integral membrane component of the F0 sector of the bacterial ATP synthase complex, forming part of the rotary c-ring that translocates protons across the membrane to drive the synthesis of ATP. It is essential for the energy metabolism of M. tuberculosis, enabling survival and persistence of the bacterium under both replicating and dormant conditions. Its unique structural features, which differ sufficiently from the human mitochondrial ATP synthase, allow selective targeting by the anti-tubercular drug bedaquiline. The high-affinity and specificity of drugs like bedaquiline for the mycobacterial c-ring make ATP synthase subunit c a central validated drug target in tuberculosis therapy, but the risk of drug resistance due to mutations must be considered[4][5][7].
Inhibition of proton translocation by binding to the c-ring, blocking rotation and thereby ATP production Destabilization of ATP synthase function, leading to energy collapse in the bacterium
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP synthase subunit c of Mycobacterium tuberculosis (AtpE).